Possible alternatives to antimicrobial therapies

Research output: Contribution to journalArticle

Abstract

The care of immunosuppressed patients has constantly improved over the years, and pharmacologic developments contributed significantly to this success. However, despite these advances, current anti-infectious agents are limited in their efficacy by either weak specificity or side effects, including suppression of bone marrow function. Control of infection will ultimately depend on reconstitution of specific immunity. Thus, adoptive cellular immunotherapy represents an attractive, low-toxicity strategy to restore specific immune surveillance, and prevent/treat potentially life-threatening disease due to pathogens relevant to the immunosuppressed host.Evidence derived from trials conducted in recipients of hematopoietic stem cell transplantation indicate that adoptive transfer of antigen-specific T cells is a feasible and safe strategy to restore protective immunity and prevent or reverse virus-associated disease.Despite the great potential, immunotherapy for viral and fungal disease still has a marginal role in the management of immunosuppressed patients. This is due to limitations inherent to the technologies and products employed, and, more importantly, to the financial and structural requirements that are associated with GMP production. However, cell therapy offers a unique opportunity to restore antipathogen immune surveillance, and it is therefore conceivable that application of this strategy will increase in the next few years.

Original languageEnglish
JournalEarly Human Development
Volume90
Issue numberSUPPL.1
DOIs
Publication statusPublished - 2014

Fingerprint

Virus Diseases
Immunity
Adoptive Immunotherapy
Adoptive Transfer
Mycoses
Hematopoietic Stem Cell Transplantation
Immunocompromised Host
Infection Control
Cell- and Tissue-Based Therapy
Immunotherapy
Patient Care
Bone Marrow
Technology
T-Lymphocytes
Antigens
Therapeutics

Keywords

  • Fungal infections
  • T cell therapy
  • Transplantation
  • Viral infections

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology
  • Medicine(all)

Cite this

Possible alternatives to antimicrobial therapies. / Zecca, Marco; Maccario, Rita; Basso, Sabrina; Comoli, Patrizia.

In: Early Human Development, Vol. 90, No. SUPPL.1, 2014.

Research output: Contribution to journalArticle

@article{9c15d6fe68674a2a88d977ec78a016ef,
title = "Possible alternatives to antimicrobial therapies",
abstract = "The care of immunosuppressed patients has constantly improved over the years, and pharmacologic developments contributed significantly to this success. However, despite these advances, current anti-infectious agents are limited in their efficacy by either weak specificity or side effects, including suppression of bone marrow function. Control of infection will ultimately depend on reconstitution of specific immunity. Thus, adoptive cellular immunotherapy represents an attractive, low-toxicity strategy to restore specific immune surveillance, and prevent/treat potentially life-threatening disease due to pathogens relevant to the immunosuppressed host.Evidence derived from trials conducted in recipients of hematopoietic stem cell transplantation indicate that adoptive transfer of antigen-specific T cells is a feasible and safe strategy to restore protective immunity and prevent or reverse virus-associated disease.Despite the great potential, immunotherapy for viral and fungal disease still has a marginal role in the management of immunosuppressed patients. This is due to limitations inherent to the technologies and products employed, and, more importantly, to the financial and structural requirements that are associated with GMP production. However, cell therapy offers a unique opportunity to restore antipathogen immune surveillance, and it is therefore conceivable that application of this strategy will increase in the next few years.",
keywords = "Fungal infections, T cell therapy, Transplantation, Viral infections",
author = "Marco Zecca and Rita Maccario and Sabrina Basso and Patrizia Comoli",
year = "2014",
doi = "10.1016/S0378-3782(14)70006-4",
language = "English",
volume = "90",
journal = "Early Human Development",
issn = "0378-3782",
publisher = "Elsevier Ireland Ltd",
number = "SUPPL.1",

}

TY - JOUR

T1 - Possible alternatives to antimicrobial therapies

AU - Zecca, Marco

AU - Maccario, Rita

AU - Basso, Sabrina

AU - Comoli, Patrizia

PY - 2014

Y1 - 2014

N2 - The care of immunosuppressed patients has constantly improved over the years, and pharmacologic developments contributed significantly to this success. However, despite these advances, current anti-infectious agents are limited in their efficacy by either weak specificity or side effects, including suppression of bone marrow function. Control of infection will ultimately depend on reconstitution of specific immunity. Thus, adoptive cellular immunotherapy represents an attractive, low-toxicity strategy to restore specific immune surveillance, and prevent/treat potentially life-threatening disease due to pathogens relevant to the immunosuppressed host.Evidence derived from trials conducted in recipients of hematopoietic stem cell transplantation indicate that adoptive transfer of antigen-specific T cells is a feasible and safe strategy to restore protective immunity and prevent or reverse virus-associated disease.Despite the great potential, immunotherapy for viral and fungal disease still has a marginal role in the management of immunosuppressed patients. This is due to limitations inherent to the technologies and products employed, and, more importantly, to the financial and structural requirements that are associated with GMP production. However, cell therapy offers a unique opportunity to restore antipathogen immune surveillance, and it is therefore conceivable that application of this strategy will increase in the next few years.

AB - The care of immunosuppressed patients has constantly improved over the years, and pharmacologic developments contributed significantly to this success. However, despite these advances, current anti-infectious agents are limited in their efficacy by either weak specificity or side effects, including suppression of bone marrow function. Control of infection will ultimately depend on reconstitution of specific immunity. Thus, adoptive cellular immunotherapy represents an attractive, low-toxicity strategy to restore specific immune surveillance, and prevent/treat potentially life-threatening disease due to pathogens relevant to the immunosuppressed host.Evidence derived from trials conducted in recipients of hematopoietic stem cell transplantation indicate that adoptive transfer of antigen-specific T cells is a feasible and safe strategy to restore protective immunity and prevent or reverse virus-associated disease.Despite the great potential, immunotherapy for viral and fungal disease still has a marginal role in the management of immunosuppressed patients. This is due to limitations inherent to the technologies and products employed, and, more importantly, to the financial and structural requirements that are associated with GMP production. However, cell therapy offers a unique opportunity to restore antipathogen immune surveillance, and it is therefore conceivable that application of this strategy will increase in the next few years.

KW - Fungal infections

KW - T cell therapy

KW - Transplantation

KW - Viral infections

UR - http://www.scopus.com/inward/record.url?scp=84897512637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897512637&partnerID=8YFLogxK

U2 - 10.1016/S0378-3782(14)70006-4

DO - 10.1016/S0378-3782(14)70006-4

M3 - Article

C2 - 24709448

AN - SCOPUS:84897512637

VL - 90

JO - Early Human Development

JF - Early Human Development

SN - 0378-3782

IS - SUPPL.1

ER -